Luying Tang
department
Pathology
Introduction

Luying Tang, MD

?

Title

Professor of Pathology

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

?

Research Interests

My experience as a pathologist and oncologist is extensive and my research has focused on clinical and molecular pathology and genetic epidemiology of breast and other women cancers. I am the co-PI of the Guangzhou Breast Cancer Study.

?

Education and Experience

1983.9-1989.6? Medical student in Sun Yat-sen Medical University, China. ???

1989.7-2000.12 Assistant Professor, Lecturer, Department of Pathology, the Third Affiliated Hospital, Sun Yat-sen University, China.

2003.12-2015.12 Associate professor, Department of Pathology, the Third Affiliated Hospital, Sun Yat-sen University,China.

2016.01-present ?Professor, Department of Pathology, the Third Affiliated Hospital, Sun Yat-sen University, China.

?

Selected Peer-reviewed Publications

1.???? Zhu RM, Lin W, Zhang W, Ren JT, Su Y, He JR, Lin Y, Su FX, Xie XM, Tang LY, Ren ZF.Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival.PLoS One, 2017 Jun 7; 12(6):e0178850.

2.???? Lin W, Lin HD, Guo XY, Lin Y, Su FX, Jia WH, Tang LY, Zheng W, Long JR, Ren ZF. Allelic expression imbalance polymorphisms in susceptibility chromosome regions and the risk and survival of breast cancer. Mol Carcinog. 2017;56(1):300-311.

3.???? Zhang W, Zhang ZZ, Tang LY, Lin Y, Su FX, Xie XM, Su XF, Ren ZF.Genetic variants in EBV reactivation-related genes and the risk and survival of breast cancer.Tumour Biol. 2016;37(6):8337-8347.

4.???? Lin W, Cen YL, Lin Y, Su FX, Wu BH, Tang LY, Ren ZF.Joint effects between urinary selenium and polymorphisms in methylation related genes on breast cancer risk.Neoplasma2015;62(3):491-9.

5.???? Wang P, Ren FM, Lin Y, Su FX, Jia WH, Su XF, Tang LY, Ren ZF. Night-shift work, sleep duration, daytime napping, and breast cancer risk. Sleep Med. 2015 Feb 3. pii: S1389-9457(15)00081-7.

6.???? Zhang Z, Chen J, Zhou J, Liu Y, Feng Z, Tang L, Jin Y.Clinicopathological study and diagnosis of rhabdoid tumor of kidney combined with metanephric adenoma. Chin Med J (Engl). 2014;127(24):4290-1.

7.???? Qin Y C, Tang L Y, Su Y, Chen L J, Su F X, Lin Y, Zhang A H, Ren Z F. Association of urinary cesium with breast cancer risk. Asian Pac J Cancer Prev, 2014, 15(22): 9785~9790.

8.???? Xi J, Su Y, Fadiel AB, Lin Y, Su FX, Jia WH, Tang LY, Ren ZF. Association of physical activity and polymorphisms in FGFR2 and DNA methylation related genes with breast cancer risk. Cancer Epidemiol. 2014, 38(6): 708~714.

9.???? Wei XL, He JR, Cen YL, Su Y, Chen LJ, Lin Y, Wu BH, Su FX, Tang LY, Ren ZF.Modified effect of urinary cadmium on breast cancer risk by selenium.Clin Chim Acta. 2015, 438: 80~85. (IF: 2.824)

10.?? Qi ML, Xi J, Chen LJ, Su Y, Cen YL, Su FX, Lin Y, Zhuang ZX, Tang LY, Ren ZF.Association of Epstein-Barr virus and passive smoking with the risk of breast cancer among Chinese women.Eur J Cancer Prev. 2014 Sep;23(5): 405-11.?

11.?? Tang LY, Chen LJ, Qi ML, Su Y, Su FX, Lin Y, Wang KP, Jia WH, Zhuang ZX, Ren ZF. Effects of passive smoking on breast cancer risk in pre/post-menopausal women as modified by polymorphisms of PARP1 and ESR1.Gene. 2013;524(2):84-9

12.?? Cen YL, Qi ML, Li HG, Su Y, Chen LJ, Lin Y, Chen WQ, Xie XM, Tang LY, Ren ZF. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status. Mol Carcinog. 2012 Nov 9. doi: 10.1002/mc.21979.(IF: 3.2)

13.?? Tang LY, Su Y, He JR, Chen WQ, Su FX, Wu BH, Lin Y, Ren ZF*. Urinary Titanium and Vanadium and Breast Cancer: A Case-Control Study. Nutr Cancer. 2012 Feb 14. [Epub ahead of print].

14.?? Chen LJ,Tang LY, He JR, Su Y, Cen YL,T Yu DD, Wu BH, Lin Y, Chen WQ, Song EW, Ren ZF. Urinary strontium and the risk of breast cancer: A case-control study in Guangzhou, China. Environmental Research, 2011; 112:212-7,DOI: 10.1016/j.envres.2011.11.005.

15.?? He JR, Chen LJ, Su Y, Cen YL,Tang LY, Yu DD, Chen WQ, Su FX, Wang SM,Song EW, Ren ZF. Joint effects of Epstein-Barr virus and polymorphisms in Interleukin-10 and Interferon-γ on Breast Cancer Risk. J. Infectious Diseases, 2011; 205(1):64-71. DOI: 10.1093/infdis/JIR710.

16.?? Su Y, Chen LJ, He JR, Yuan XJ, Cen YL, Su FX, Tang LY, Zhang AH, Chen WQ, Lin Y, Wang SM, Ren ZF. Urinary rubidium in breast cancers. Clinica Chimica Acta. 2011; 412(23-24):2305-9.

17.?? He JR, Tang LY, Yu DD, Su FX, Song EW, Lin Y, Wang SM, Lai GC, Chen WQ, Ren ZF. Epstein-Barr virus and breast cancer: Serological study in a high-incidence area of nasopharyngeal carcinoma. Cancer Letters, 2011 Jun 24. 309(2):128-36. doi:10.1016/j.canlet.2011.05.012.

18.?? Tang L , He D, Zhou J , Feng Z , Zhang Z , Yu D, Ren Z , Shao C. Differences of HER-2 status in breast cancer tissues detected by FISH and IHC and its related characteristics. Chinese Journal of Breast Disease, 2010, (1):41-44. (Chinese)

19.?? Tang L, Jin Y, Liu Y, Feng Z, Shao C, Ren Z. Expressions of HER-2, p53, Estrogen Receptor, and Progesterone Receptor in Tissues of Invasive Ductal Breast Carcinoma with Different Clinical Stages. Journal of Sun Yat-Sen University: Medical Sciences,2009, 30(4):454-457. (Chinese)

20.?? Tang LY, Ren ZF, Zhuang Zhixiong, et al. Distribution of PARP pseudogene polymorphism and association with susceptibility to lung cancer in Chinese people. Chinese Journal of Medical Genetics, 2001; 18(6):415-417. (Chinese)

21.?? Tang LY, Ren ZF, Zhou XP, Su ZL, Zhuang ZX. Association between ABO Blood Group and Smoking with Lung cancer Susceptibility. Chinese Journal of Control of Chronic Non-communication Diseases, 2001; 9(2):70-71. (Chinese)

22.?? Tang LY, Ren ZF, Su ZL, Zhuang ZX. PARP induced activity of white blood cells in population and the characteristics of patients with lung cancer. Chinese Journal of clinics and rehabilitation of tumor. 2001; 8: 24-25, 16. (Chinese)

23.???? Tang LY, Su ZL, Feng ZY, Liu Y, Shao CK, Ren ZF. The expression and implication of P53 and HER-2 in lung cancer tissues. China Journal of Modern Medicine, 2001; 11 (7): 20-21. (Chinese)
?

Research Support

Role: Co-Principal Investigator?? ???

Agency: National Natural Science Foundation of China, No: 81773515??

Period:? 01/01/18-12/31/2021

Title: Associations of epigenetic effects of cadmium or/and selenium with the risk and prognosis of breast cancer

?

Role: Principal Investigator?? ?

Agency: National Natural Science Foundation of China No: 81172759????

Period:? 01/01/12-12/31/12

Title: Association between clincopathological characteristics of breast cancer and cadmium and cadmium-related genetic polymorphisms

?

Role: Co-Principal Investigator?? ???

Agency: National Natural Science Foundation of China, No: 81072383??

Period:? 01/01/11-12/31/13

Title: Relation of FGFR2 methylation to cadmium and other environmental factors and the contribution to risk of breast cancer

?

Role:? Co-Principal Investigator?? ?

Agency: Education Ministry of China????? ?????

Period:? 01/01/09-12/31/11

Title: The association of breast cancer with cadmium and related gene polymorphisms.

?

Contact

Department of Pathology, The Third Affiliated Hospital, Sun Yat-Sen University, No. 600 Tianhe Rd, Guangzhou 510630, China

Appointment Phone:?+86-20-85253436,18922103782

?

?

?